[Elsevier] First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

icarus Post time Yesterday 23:15 | Show all posts |Read mode
This post will be closed automatically in 2026-06-22 23:14
Reward10points

First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trialLancet Oncol




. 2021 Feb;22(2):198-211.

doi: 10.1016/S1470-2045(20)30641-0. Epub 2021 Jan 18.
https://pubmed.ncbi.nlm.nih.gov/33476593/
https://linkinghub.elsevier.com/retrieve/pii/S1470-2045(20)30641-0

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
jakir_ete_ruet Post time Yesterday 23:15 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list